|
Clonazepam Orally Disintegrating Tablets
|
|
Klonopin Wafer
|
Clonazepam Orally Disintegrating Tablets Clinical Trials
- A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
ClinicalTrials.gov Identifier: NCT00139854 - Completed
Anxiety
- A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00139867 - Completed
Parkinson''s Disease
- Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
ClinicalTrials.gov Identifier: NCT00443872 - Recruiting
Parkinson's Disease
- A Randomized, Open-Label, Two-Way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects with Diabetic Gastroparesis
ClinicalTrials.gov Identifier: NCT00139893 - Completed
Diabetic gastroparesis
- Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
Chronic Idiopathic Thrombocytopenic Purpura (ITP)
- Oral Disintegrating Ondansetron Tablet to Reduce Vomiting from Gastroenteritis in a Pediatric Emergency Department
ClinicalTrials.gov Identifier: NCT00120744 - Active, not recruiting
Gastroenteritis; Vomiting; Diarrhea; Dehydration
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- Therapies for Treatment-Resistant Panic Disorder Symptoms
ClinicalTrials.gov Identifier: NCT00118417 - Active, not recruiting
Panic Disorder
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
Parkinson's Disease
- Safety and Pharmacokinetics of XL647 Administered Orally to Subjects with Solid Tumors
ClinicalTrials.gov Identifier: NCT00086528 - Active, not recruiting
Cancer
- Study of XL820 Given Orally Daily to Subjects With Solid Tumors
ClinicalTrials.gov Identifier: NCT00350831 - Recruiting
Cancer
- Study of XL647 Administered Orally Daily to Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00336765 - Recruiting
Cancer
- Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics
ClinicalTrials.gov Identifier: NCT00514618 - Recruiting
Diabetes, Gestational
- Study Evaluating Orally Administered Moxidectin in Subjects With Onchocerca Volvulus Infection
ClinicalTrials.gov Identifier: NCT00300768 - Recruiting
Onchocerciasis
- Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
ClinicalTrials.gov Identifier: NCT00458835 - Active, not recruiting
Allergic Rhinitis
- Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
Pain
- An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
Analgesia
- Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
Allergy
- A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment.
ClinicalTrials.gov Identifier: NCT00438048 - Recruiting
Primary Sjogren; Secondary Sjogren; Xerostomia
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
Parkinson Disease
- A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00397046 - Recruiting
Tumors
- Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
Allergy
- Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
ClinicalTrials.gov Identifier: NCT00417261 - Recruiting
Healthy
- A Randomized, Double-Blind, Placebo-Controlled Trial with 0.75mg Pramipexole (BI•Sifrol®) Orally Once Daily to Investigate the Efficacy and Safety for 6 Weeks in Patients with Primary Restless Legs Syndrome.
ClinicalTrials.gov Identifier: NCT00152997 - Completed
Restless Legs Syndrome
- A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
Schizophrenia; Psychotic Disorders
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
Analgesics, Opioid.; Pain
- PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-Arm)
ClinicalTrials.gov Identifier: NCT00574210 - Recruiting
Seasonal Allergic Rhinitis; Hay Fever; Rhinoconjunctivitis
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
Chronic Hepatitis B
- A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
Schizophrenia
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.
ClinicalTrials.gov Identifier: NCT00410358 - Recruiting
Advanced Solid Tumors
- Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov Identifier: NCT00509145 - Recruiting
Multiple Sclerosis
- An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor
ClinicalTrials.gov Identifier: NCT00441610 - Recruiting
Advanced Solid Tumors
- Lopinavir Capsules to Kaletra or Invirase Tablets
ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
HIV Infections
- A Study of the Safety, and Anti-Tumor Activity of ADH300004 and 5-Fluorouracil Administered Orally in a Weekly Schedule to Subjects With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov Identifier: NCT00319683 - Recruiting
Hepatocellular Carcinoma
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
Essential Hypertension
- A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00487058 - Recruiting
Advanced Solid Tumors
- A Study of the Safety, Pharmacokinetics of 5 Fluorouracil, and Anti-Tumor Activity of ADH300004 and 5 Fluorouracil Administered Orally to Subjects With Incurable Solid Tumors.
ClinicalTrials.gov Identifier: NCT00264472 - Recruiting
Neoplasms
- Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate
ClinicalTrials.gov Identifier: NCT00525213 - Not yet recruiting
Rheumatoid Arthritis
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
Allergy
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
Allergy
- Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
Onychomycosis of the Toenail
- A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00540501 - Not yet recruiting
Healthy Volunteer
- Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects
ClinicalTrials.gov Identifier: NCT00550381 - Not yet recruiting
Healthy
- Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
Chronic Pain
- Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
Malaria
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
Alzheimer Disease
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
Schizophrenia; Bipolar Disorder
- Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
Seasonal Allergic Rhinoconjunctivitis
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00501618 - Recruiting
Schizophrenia; Schizoaffective Disorder
- Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
Chronic Lymphocytic Leukemia
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
Menopause
- A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
HIV Infection
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
Alzheimer's Disease
- A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
HIV Infection
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
Menopause
- Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
Pain; Cancer
- Mycophenolate Mofetil in Membranous Nephropathy
ClinicalTrials.gov Identifier: NCT00135967 - Completed
Glomerulonephritis, Membranous
- Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
Pain; Cancer
- Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
Posthepatitic Cirrhosis
- Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
Smoking Cessation
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
Crohn''s Disease
- Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
Pyuria; Urinary Tract Infections
- Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
Myelodysplastic Syndrome (MDS)
- Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
Urinary Tract Infection
- Evaluation of Clonazepam and Paroxetine for Panic Disorder with Depression
ClinicalTrials.gov Identifier: NCT00031317 - Completed
Panic Disorder
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
Parkinson's Disease
- Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
Tobacco Dependence
- Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
Rheumatoid Arthritis
- Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
Epilepsy
- Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
Restless Legs Syndrome
- Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
ClinicalTrials.gov Identifier: NCT00311350 - Completed
Postoperative Complications; Constipation
- Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
ClinicalTrials.gov Identifier: NCT00025740 - Completed
Post Traumatic Stress Disorder
- A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00501397 - Completed
Type 2 Diabetes Mellitus
- To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
ClinicalTrials.gov Identifier: NCT00258050 - Completed
Cancer
- Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
ClinicalTrials.gov Identifier: NCT00035347 - Completed
Pneumonia
- Trial Comparing Effects of Xyrem taken Orally and Modafinil with Placebo in Treating Daytime Sleepiness in Narcolepsy
ClinicalTrials.gov Identifier: NCT00066170 - Completed
Narcolepsy
- Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors
ClinicalTrials.gov Identifier: NCT00503412 - Completed
Advanced Solid Metastatic Tumor
- A Study of NM-3 Administered Orally in Patients with Advanced Solid Tumors.
ClinicalTrials.gov Identifier: NCT00046696 - Completed
Neoplasms
- Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
ClinicalTrials.gov Identifier: NCT00544024 - Completed
Malaria
- Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00219882 - Completed
Cystic Fibrosis
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
ClinicalTrials.gov Identifier: NCT00350168 - Completed
Hypertension
- Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
ClinicalTrials.gov Identifier: NCT00062556 - Completed
Intermittent Claudication; Peripheral Vascular Disease
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
ClinicalTrials.gov Identifier: NCT00353912 - Completed
Hypertension
- Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
ClinicalTrials.gov Identifier: NCT00328718 - Completed
Asthma
- Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00396799 - Completed
Menopause
- Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
ClinicalTrials.gov Identifier: NCT00167921 - Completed
Atrophic Vaginitis
- A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
ClinicalTrials.gov Identifier: NCT00500201 - Completed
Schizophrenia
- Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
ClinicalTrials.gov Identifier: NCT00550329 - Completed
Diabetes Mellitus, Non-Insulin-Dependent; Hyperglycemia
- A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
ClinicalTrials.gov Identifier: NCT00239395 - Completed
Osteoarthritis
- An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
ClinicalTrials.gov Identifier: NCT00000672 - Completed
HIV Infections
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
ClinicalTrials.gov Identifier: NCT00255528 - Completed
Hypertension
- A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
ClinicalTrials.gov Identifier: NCT00232154 - Completed
Sinusitis
- An Evaluation of the Efficacy and Safety of Tegaserod 6 Mg Bid Given Orally to Chinese Patients with Chronic Constipation
ClinicalTrials.gov Identifier: NCT00139568 - Completed
Chronic constipation
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
ClinicalTrials.gov Identifier: NCT00344383 - Completed
Metrorrhagia
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
ClinicalTrials.gov Identifier: NCT00002408 - Completed
Diarrhea; HIV Infections
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
